Role of Prolonged Mitotic Checkpoint Activation in the Formation and Treatment of Cancer

Overview

Journal Future Oncol

Specialty Oncology

Date 2009 Nov 12

PMID 19903065

Citations 13

Authors

W Brian Dalton

Vincent W Yang

Affiliations

Soon will be listed here.

Abstract

Mitotic abnormalities are a common feature of human cancer cells, and recent studies have provided evidence that such abnormalities may play a causative, rather than merely incidental role, in tumorigenesis. One such abnormality is prolonged activation of the mitotic checkpoint, which can be provoked by a number of the gene changes that drive tumor formation. At the same time, antimitotic chemotherapeutics exert their clinical efficacy through the large-scale induction of prolonged mitotic checkpoint activation, indicating that mitotic arrest is influential in both the formation and treatment of human cancer. However, how this influence occurs is not well understood. In this perspective, we will discuss the current evidence in support of the potential mechanisms by which prolonged activation of the mitotic checkpoint affects both tumorigenesis and antimitotic chemotherapy.

Citing Articles

Selective Vulnerability of Senescent Glioblastoma Cells to BCL-XL Inhibition.

Rahman M, Olson I, Mansour M, Carlstrom L, Sutiwisesak R, Saber R Mol Cancer Res. 2022; 20(6):938-948.

PMID: 35191501 PMC: 9196639. DOI: 10.1158/1541-7786.MCR-21-0029.

Heterogeneities in Cell Cycle Checkpoint Activation Following Doxorubicin Treatment Reveal Targetable Vulnerabilities in Mutated Ultra High-Risk Neuroblastoma Cell Lines.

Odborn Jonsson L, Sahi M, Lopez-Lorenzo X, Keller F, Kostopoulou O, Herold N Int J Mol Sci. 2021; 22(7).

PMID: 33915913 PMC: 8036447. DOI: 10.3390/ijms22073664.

The balance between mitotic death and mitotic slippage in acute leukemia: a new therapeutic window?.

Luserna di Rora A, Martinelli G, Simonetti G J Hematol Oncol. 2019; 12(1):123.

PMID: 31771633 PMC: 6880427. DOI: 10.1186/s13045-019-0808-4.

Disruption of Telomere Integrity and DNA Repair Machineries by KML001 Induces T Cell Senescence, Apoptosis, and Cellular Dysfunctions.

Cao D, Zhao J, Nguyan L, Nguyen L, Khanal S, Dang X Front Immunol. 2019; 10:1152.

PMID: 31191531 PMC: 6540964. DOI: 10.3389/fimmu.2019.01152.

The origins and functions of hepatic polyploidy.

Zhang S, Lin Y, Tarlow B, Zhu H Cell Cycle. 2019; 18(12):1302-1315.

PMID: 31096847 PMC: 6592246. DOI: 10.1080/15384101.2019.1618123.

References

Wu G . p53 and chemosensitivity. Nat Med. 1996; 2(3):255-6. DOI: 10.1038/nm0396-255a. View

Strobel T, Swanson L, Korsmeyer S, Cannistra S . BAX enhances paclitaxel-induced apoptosis through a p53-independent pathway. Proc Natl Acad Sci U S A. 1996; 93(24):14094-9. PMC: 19500. DOI: 10.1073/pnas.93.24.14094. View

Diaz-Rodriguez E, Sotillo R, Schvartzman J, Benezra R . Hec1 overexpression hyperactivates the mitotic checkpoint and induces tumor formation in vivo. Proc Natl Acad Sci U S A. 2008; 105(43):16719-24. PMC: 2570608. DOI: 10.1073/pnas.0803504105. View

Seymour J, Juneja S, Campbell L, Ellims P, Estey E, Prince H . Secondary acute myeloid leukemia with inv(16): report of two cases following paclitaxel-containing chemotherapy and review of the role of intensified ara-C therapy. Leukemia. 1999; 13(11):1735-40. DOI: 10.1038/sj.leu.2401552. View

Dissing M, Le Beau M, Pedersen-Bjergaard J . Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors?. J Clin Oncol. 1998; 16(5):1890-6. DOI: 10.1200/JCO.1998.16.5.1890. View

Yang Z, Loncarek J, Khodjakov A, Rieder C . Extra centrosomes and/or chromosomes prolong mitosis in human cells. Nat Cell Biol. 2008; 10(6):748-51. PMC: 2430725. DOI: 10.1038/ncb1738. View

Allan L, Clarke P . Phosphorylation of caspase-9 by CDK1/cyclin B1 protects mitotic cells against apoptosis. Mol Cell. 2007; 26(2):301-10. DOI: 10.1016/j.molcel.2007.03.019. View

Stevens J, Liu G, Bremer S, Ye K, Xu W, Xu J . Mitotic cell death by chromosome fragmentation. Cancer Res. 2007; 67(16):7686-94. DOI: 10.1158/0008-5472.CAN-07-0472. View

Weaver B, Cleveland D . Does aneuploidy cause cancer?. Curr Opin Cell Biol. 2006; 18(6):658-67. DOI: 10.1016/j.ceb.2006.10.002. View

10.

Sisken J, Bonner S, Grasch S . The prolongation of mitotic stages in SV40-transformed vs nontransformed human fibroblast cells. J Cell Physiol. 1982; 113(2):219-23. DOI: 10.1002/jcp.1041130206. View

11.

Stewart Z, Leach S, Pietenpol J . p21(Waf1/Cip1) inhibition of cyclin E/Cdk2 activity prevents endoreduplication after mitotic spindle disruption. Mol Cell Biol. 1998; 19(1):205-15. PMC: 83879. DOI: 10.1128/MCB.19.1.205. View

12.

van Deursen J . Rb loss causes cancer by driving mitosis mad. Cancer Cell. 2007; 11(1):1-3. DOI: 10.1016/j.ccr.2006.12.006. View

13.

Fujiwara T, Bandi M, Nitta M, Ivanova E, Bronson R, Pellman D . Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature. 2005; 437(7061):1043-7. DOI: 10.1038/nature04217. View

14.

Perez-Moreno M, Song W, Pasolli H, Williams S, Fuchs E . Loss of p120 catenin and links to mitotic alterations, inflammation, and skin cancer. Proc Natl Acad Sci U S A. 2008; 105(40):15399-404. PMC: 2547465. DOI: 10.1073/pnas.0807301105. View

15.

Austin K, Gupta Jr M, Coats S, Tulpule A, Mostoslavsky G, Balazs A . Mitotic spindle destabilization and genomic instability in Shwachman-Diamond syndrome. J Clin Invest. 2008; 118(4):1511-8. PMC: 2263145. DOI: 10.1172/JCI33764. View

16.

Sisken J, Bonner S, Grasch S, Powell D, Donaldson E . Alterations in metaphase durations in cells derived from human tumours. Cell Tissue Kinet. 1985; 18(2):137-46. DOI: 10.1111/j.1365-2184.1985.tb00642.x. View

17.

Royle S, Bright N, Lagnado L . Clathrin is required for the function of the mitotic spindle. Nature. 2005; 434(7037):1152-7. PMC: 3492753. DOI: 10.1038/nature03502. View

18.

Weaver B, Cleveland D . Decoding the links between mitosis, cancer, and chemotherapy: The mitotic checkpoint, adaptation, and cell death. Cancer Cell. 2005; 8(1):7-12. DOI: 10.1016/j.ccr.2005.06.011. View

19.

Kienitz A, Vogel C, Morales I, Muller R, Bastians H . Partial downregulation of MAD1 causes spindle checkpoint inactivation and aneuploidy, but does not confer resistance towards taxol. Oncogene. 2005; 24(26):4301-10. DOI: 10.1038/sj.onc.1208589. View

20.

Menssen A, Epanchintsev A, Lodygin D, Rezaei N, Jung P, Verdoodt B . c-MYC delays prometaphase by direct transactivation of MAD2 and BubR1: identification of mechanisms underlying c-MYC-induced DNA damage and chromosomal instability. Cell Cycle. 2007; 6(3):339-52. DOI: 10.4161/cc.6.3.3808. View